Implications of use of contaminated drugs: a developing world scenario

Document Type

Article

Department

Pathology and Microbiology

Abstract

Infections after use of inadequately sterilised therapeutic products have been reported worldwide. We believe that, in the absence of well established surveillance and notification procedures (as is often the case in developing countries), such instances are frequently not detected, and contaminated drugs continue to be marketed.

Publication (Name of Journal)

The Lancet

Share

COinS